LEADER 02242oam  2200445 a 450 
001 9910696238803321
005 20071120162216.0
035   $a(CKB)5470000002376434
035   $a(OCoLC)173682812
035   $a(EXLCZ)995470000002376434
100   $a20071005d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHigh-containment biosafety laboratories$b[electronic resource] $epreliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Keith Rhodes
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007]
215   $a35 pages $cdigital, PDF file
225 1 $aTestimony ;$vGAO-08-108 T
300   $aTitle from title screen (viewed on Oct. 5, 2007).
300   $a"For release on delivery...October 4, 2007."
300   $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
320   $aIncludes bibliographical references.
330   $aThis testimony addresses (1) the extent to which there has been a proliferation of BSL-3 and BSL-4 labs, (2) federal agencies' responsibility for tracking this proliferation and determining the associated risks, and (3) the lessons that can be learned from recent incidents at three high-containment biosafety labs.
517   $aHigh-containment biosafety laboratories 
606   $aMicrobiological laboratories$zUnited States
606   $aMedical laboratories$zUnited States
615  0$aMicrobiological laboratories
615  0$aMedical laboratories
700   $aRhodes$b Keith A$01380699
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bEJB
801  1$bEJB
801  2$bGPO
906   $aBOOK
912   $a9910696238803321
996   $aHigh-containment biosafety laboratories$93544174
997   $aUNINA